Reta glucagon-like peptide-1 (GLP-1) receptor agonists offer a groundbreaking strategy to diabetes management. These innovative drugs operate by mimicking the physiological actions of GLP-1, a hormone released by the https://companyspage.com/story5775586/the-emerging-role-of-glp-1-receptor-agonists-in-diabetes-management